Do intranasal corticosteroids affect childhood growth?

Allergy: European Journal of Allergy and Clinical Immunology, Supplement

Volumn 55, Issue 62, 2000, Pages 15-18

  Allen, D B ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BECLOMETASONE DIPROPIONATE; BUDESONIDE; CORTICOSTEROID; METHYLPREDNISOLONE; MOMETASONE FUROATE; TERFENADINE; TRIAMCINOLONE;

ALLERGIC RHINITIS; CHILD; CHILD GROWTH; CHILDHOOD DISEASE; CONFERENCE PAPER; DISEASE SEVERITY; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG EFFECT; GASTROINTESTINAL ABSORPTION; GROWTH INHIBITION; HUMAN; PRIORITY JOURNAL;

EID: 0033937723     PISSN: 01081675     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1398-9995.2000.00704.x     Document Type: Conference Paper

References (16)

1. ALLEN DB. Growth suppression by glucocorticoid therapy. In: ROSENFIELD RL, editor. Growth and growth disorders. Philadelphia: WB Saunders, 1996:699-718.
2. KELLY HW. Establishing a therapeutic index for the inhaled corticosteroids. J Allergy Clin Immunol 1998;102:S36-S51.
3. ALLEN DB. Influence of inhaled corticosteroids on growth: a pediatric endocrinologist's perspective. Acta Paediatr 1998;87:123-129.
4. VERBERNE AAPH, FROST C, DIPSTAT MA, et al. One year treatment with salmeterol compared to BDP in children with asthma. Am J Respir Crit Care Med 1997;156:688-695.
5. ALLEN DB, BRONSKY EA, LAFORCE CF, et al. Growth in asthmatic children treated with fluticasone propionate. J Pediatr 1998;132:472-477.
6. MARTIN AJ, LANDAU LI, PHELAN PD. The effect on growth of childhood asthma. Acta Paediatr Scand 1981;70:683-688.
7. WOLTHERS OD, PEDERSEN S. Knemometric assessment of systemic activity of once daily intranasal dry-powder budesonide in children. Allergy 1994;49:96-99.
8. WILSON AM, SIMS EJ, MCFARLANE LC, LIPWORTH BJ. Effects of intranasal corticosteroids on adrenal, bone and blood markers of systemic activity in allergic rhinitis. J Allergy Clin Immunol 1998;102:598-604.
9. DALEY-YATES PT, MCALLISTER T. Systemic bioavailability of fluticasone propionate administered as nasal drops (FP drops) and aqueous nasal spray formulations (FPANS). Allergy 1998;53(Abs P412):158.
10. DEAN HJ, SCHENTAG CT, WINTER JS. Predictive value of short-term growth using knemometry in a large population of healthy children. Acta Paediatr Scand 1990;79:57-63.
11. WOLTHERS OD, PEDERSEN S. Short-term growth in children with allergic rhinitis treated with oral antihistamine, depot and intranasal glucocorticosteroids. Acta Paediatr 1993;82:635-640.
12. MÖLLER C, EK L, SVENNSON I. Nasal budesonide to children for 5 years. Allergy Clin Immunol News 1994;6 Suppl 2 (Abstract):427.
13. RACHELEFSKY GS, CHERVINSKY P, MELTZER EO. An evaluation of the effects of beclomethasone dipropionate aqueous nasal spray Vancenase AQ (VNS) on long-term growth in children. J Allergy Clin Immunol 1998;101(1) Pt 2.Abs 979:5236.
14. SIMONS FE. A comparison of BDP, salmeterol, and placebo in children with asthma. Canadian BDP Dipropionate-Salmeterol Xinafoate Study Group. N Engl J Med 1997;337:1659-1665.
15. ALLEN DB, BRONSKY EA, LAFORCE CF, et al. Growth in asthmatic children treated with FP propionate. FP Propionate Asthma Study Group. J Pediatr 1998;132:472-477.
16. FIOCCHI A, HUGHES S, MEDLEY HV. Effects of inhaled and intranasal corticosteriods on growth velocity in children; a comparison of fluticasone propionate with beclomethasone dipropionate. Eur Respir J 1999;14 Suppl 30:13S.